Open Nav
2017 Schedule of Events

2017 Schedule of Events coming soon. Check back for updates.

2016 Session Descriptions

Pre-Conference Seminar
Regenerative Medicine & Cell Therapy: A New Paradigm in Human Health

Regenerative medicine represents a new paradigm in human health, with the potential to solve unmet medical needs, addressing the underlying causes of diseases. Regenerative medicine and cell therapy harness the power of stem cells, tissue engineering and biomaterials to repair, regenerate or replace cells, tissues and organs. These technologies have the potential to treat, control and possibly cure some of the most debilitating and costly diseases in the world today, such as heart diseases and diabetes. This pre-conference plenary will bring regional experts to discuss challenges and present success cases on this subject.


  • Patricia Beltrão, Professor,  Universidade de São Paulo (USP)
  • Hugo Cabrera, Business Development Director, Cellus Medicina Regenerative
  • Renata Miranda Parca, Specialist, Department of Blood, Tissues, Cells and Organs, Agência Nacional de Vigilância Sanitária (ANVISA)
  • Graciela Pignatari, Executive Director, Tismoo
  • Marcos Valadares, Co-founder, PluriCell
  • Douglas Valverde, Chief Executive Officer & President, Techtrials


Welcome Address



Opening Plenary: “The Value of the Bioeconomy”

Our distinguished panelists will discuss the value of biotech innovation to society and explore the strengths and opportunities that exist in Latin American to drive innovation forward.  What makes the region so attractive? Why focus on biobased solutions now?  Our dynamic speakers will seek to answer these questions.  Topics to include value of innovation in health, the cost competitiveness of biomass in the region, the creation of value added products such as fine and specialty chemicals, fuels, and processes, and investments in biobased technologies.  

Moderator: Jim Greenwood, Chief Executive Officer, BIO


  • Igor Bueno, Superintendent of the Health, Agribusiness and Chemicals Department, Brazilian Innovation Financing Agency (FINEP)*
  • Marco Antonio Fireman, Secretary of Science, Technology and Strategic Inputs, Ministry of Health
  • Bernardo Gradin, Chief Executive Officer, GranBio
  • Hadyn Parry, Chief Executive Officer, Oxitec
  • Luiz Otávio Pimentel, President, Brazilian Patent and Trademark Office (INPI)
  • Marcos Vinicius de Souza, Secretary of Innovation, Ministry of Industry, Foreign Trade and Services (MDIC)


Minas Lunch Seminar

Grand Hyatt São Paulo / Room Aurum – Av. Nações Unidas, 13301 – Vila Cordeiro, São Paulo/SP

The Federation of Industries of the State of Minas Gerais (FIEMG), in cooperation with Biominas Brasil, invites you to attend the lunch seminar Invest in Minas that will be held at the BIO Latin America Conference. Your company will be introduced to the best investment opportunities in the State, the existing ecosystem of Biotechnology in  Minas Gerais and how the government can help investors that want to settle their companies there.

12:00 pm: Welcome Network Lunch

12:30 pm: Presentations

  • Eduardo Emrich, CEO, Biominas Brasil
  • Guilherme Emrich, President of the Advisory Board, Biominas Brasil
  • Marcos Mandacaru, Strategic and International Affairs of Strategic Priorities Office, FIEMG
  • Cristiane Serpa, President, The Integrated Development Institute of Minas Gerais (INDI)
  • Marcos Vinicius de Souza, Secretary of Innovation, Ministry of Industry, Foreign Trade and Services (MDIC)

1:30 pm – 2:30pm: Questions and Answers + One-on-One meetings

Information: This seminar is a free admission for the companies that are participating at the BIO Latin Conference and has a limited vacancy. Please confirm your participation to the e-mail addresses:


Industrial and Environmental Leadership Sessions


Building a Successful Industrial Biotech Start-Up

Startup companies will discuss exciting new technologies, and how to bring these technologies to market, in addition to highlighting the role of venture funding, collaborations and key partnerships, and the lessons learned in the challenges to scale.

Moderator: Fernando Reinach, Managing Partner, Fundo Pitanga 


  • Marcelo do Amaral, PhD, Chief Executive Officer, GlobalYeast 
  • Sérgio Robles Reis de Queiroz, Special Advisor to the Scientific Director, São Paulo Research Foundation (FAPESP)
  • Marcio Schittini, Director, EcoMetano 


Biorefinery Scale-Up Challenges

Our panelists will discuss the challenges faced in scaling up biorefineries, what is driving companies to commercialize second generation feedstocks, and what lessons have been learned along the way. 

Moderator: Luciano Cunha de Sousa, New Business Coordinator, Secretariat of Innovation,  Ministry of Industry, Foreign Trade and Services (MDIC)



Food & Cosmetic Ingredients Boosted by Biotechnology

Our panelists will discuss the importance of using biotechnology to boost their competitiveness in international markets.

Moderator: Bruno Brasil, PhD, R&D Assitant Director, Embrapa Agroenergy


  • Adrian Martin Pohlit, General Coordinator of the Amazon Biotechnology Center (CBA) and Researcher of the National Institute of Amazonian Research (INPA)
  • Roberta Roesler, PhD, Research & Development Manager, Natura 
  • Daniel Sabara, Chief Executive Officer, Beraca
  • Bruno Sato, Performance Materials, International Raw Material Department, L'Oréal 


Synthetic Biology- Technology for the Future

What are the technologies for the future?  How will the implications of synthetic biology impact the growth in this sector? Our panelists will demonstrate the impact of synthetic biology.

Moderator: Paulo Coutinho, PhD, Director, SENAI Innovation Institute in Biosynthetic


  • John Biggs, Research & Development, Director Latin America, Dow
  • Bernard Chaud, Vice President of Industrial Strategy, Global Bioenergies
  • Mateus Schreiner Garcez Lopes, PhD, Innovation in Renewable Technologies, Manager, Braskem


Regulatory Barriers to Growing the Bio-Based Economy

This session will focus on regulatory hurdles faced by the industrial biotech sector specifically with regard to biological diversity and the biological diversity legal framework.  

Moderator: Thiago Falda, Director of Regulatory Affairs, Brazilian Industrial Biotechnology Association (ABBI)


  • Pedro Luis Fernandes, Vice President of Corporate Affairs & Sustainability for Latin America, Novozymes
  • Rafael Marques, Head of CGEN, Ministry of Environment, Brazil  
  • Anita Pissolito, Partner, Nascimento Mourão Advogados
  • Thiago Terada, Head of Sustainability and Corporate Affairs, Beraca


The Role for Academia in a Growing Bio-Based Economy

Our panelists will discuss the relationship between academics and the business community, identify disconnects between the two, highlight the status of bioscience, and talk about academic partnerships to advance industrial bioscience.

Moderator: Christophe Luguel, Head of International Affairs, Cluster Industries & Agro-resources (IAR)


  • Wilson Araujo, PhD, Science Technology & Innovation Corporate Advisor, Brazil
  • José Vitor Bomtempo, PhD, Professor of the Chemicals School, Universidade Federal do Rio de Janeiro
  • Jaime Finguerut, Industrial Strategic Development, Centro De Tecnologia Canavieira (CTC)
  • Gonçalo Amarante Guimarães Pereira, PhD, Chief Scientific Officer, GranBio


Industrial Property in the Latin America Market

Panelists will discuss new industrial property laws in Latin America, and how these laws affect the growth of the industrial biotechnology sector in the region. 

Moderator: Gabriel Di Blasi, Partner, Di Blasi, Parente & Associados


  • Laura Hammel, Intellectual Property Attaché for Mercosur, Guianas, and Suriname, U.S. Commercial Service 
  • Matthew McBride, Manager, Science IP, Chemical Abstracts Service
  • Júlio César Moreira, Director of Patents, Instituto Nacional da Propriedade Industrial (INPI)
  • Raquel Rinke, Laboratory Manager, Royal DSM  


Below50: Growing the Global Market for Sustainable Fuels

Below50 aims to reframe the old perception of low carbon fuels, and help create the conditions for their successful development and commercialization.  Our speakers will discuss how to create cross-sectoral business opportunities in new and mature markets, highlight the importance of working with government to promote public private partnerships and join initiatives, and expand upon Below50 as the global, unified voice for sustainable fuels.

Moderator: Gerard Ostheimer, Global Lead, Sustainable Bioenergy Group, UN Sustainable Energy For All (SE4ALL)


  • José Guilherme Nogueira, Chief Executive Officer , Socicana
  • Aurea Nardelli, Regional Director of Business Development, South America, Roundtable on Sustainable Biomaterials (RSB)
  • Pedro Scorza, Director of Technical Operations, Gol Airlines  
  • Atul Thakrar, President, DSM Bio-based Products & Services
  • Emerson de Vasconcelos, Regional President LatAM, Novozymes 


Human Health Leadership Sessions

Overview of Critical Trends Affecting the Innovative Industry in Latin America

The research and development of innovative products in the biotechnology space is an increasingly international endeavor, which requires the close coordination and collaboration of experts from diverse sectors around the globe. Esteemed industry, government and finance experts will share their views on global partnerships and research projects in healthcare throughout Latin America.

Moderator: David Thomas, Senior Director, Industry Research and Policy Analysis, BIO


  • Paulo Braga, Group Vice President, Clinical & Medical Affairs for Latin America, Genzyme/Sanofi
  • Rafael Henrique Rodrigues Moreira, Director, Department of Innovative Technologies, Ministry of Industry, Foreign Trade and Services (MDIC)
  • João Sanches, Senior Advisor, Albright Stonebridge Group


Regulation of Biological Medicines in Brazil

A panel with ANVISA experts to discuss the regulatory environment for biological products in Brazil and to discuss the role of the regulatory agency in helping to spur economic growth in the sector.


  • Márcia Gonçalves de Oliveira, Manager, Department of Pharmacovigilance, Agência Nacional de Vigilância Sanitária (ANVISA)
  • José Carlos Moutinho, Director, Sanitary Monitoring and Control, Agência Nacional de Vigilância Sanitária (ANVISA)
  • Gustavo Mendes Lima Santos, Coordinator, Therapeutic Equivalence, Agência Nacional de Vigilância Sanitária (ANVISA) 
  • Fanny Nascimento Moura Viana, Specialist, Department of Clinical Trials, Agência Nacional de Vigilância Sanitária (ANVISA)
  • Vanessa Lucas Xavier, Specialist, Department of Biologics Products, Agência Nacional de Vigilância Sanitária (ANVISA)


Innovative Entrepreneurship and Corporate Venture

Companies are increasingly looking for startups as a way to access innovation. On the other side, universities and research centers are expanding their initiatives to better prepare researchers and students to become more innovative and entrepreneurs. Policy makers and development institutions must support initiatives that create bridges between corporates and startups. This session will present this changing landscape and discuss issues such as: What are the companies’ objectives and strategies? What is the role of accelerator programs? How to grow this ecosystem?

Moderator: Eduardo Emrich, President & Chief Executive Officer, Biominas Brasil


  • Bob Blouin, Dean, University of North Carolina, Eshelman School of Pharmacy
  • João Paulo Pieroni, Head of Industry and Services Health Department, The Brazilian Development Bank (BNDES)
  • Claudio Terra, Director of Innovation and Knowledge Management, Hospital Albert Einstein
  • Pedro Waengertner, Chief Executive Officer, ACE Aceleratech & President, Associação Brasileira de Empresas Aceleradoras de Inovação e Investimento (ABRAII)


Public-Private Partnerships:  How to Prevent and Solve Epidemics and Pandemics from Dengue to Zika

This session will focus on advancements in the diagnosis and treatments of these diseases. In addition to companies working in this space, the panel will discuss activities undertaken at the international organizational level with a particular focus on the WHO’s research and development blueprint for action to prevent epidemics which was presented to Member States at the World Health Assembly in May 2016.

Moderator: Mariana Lenharo, Reporter, Portal G1, Globo Network


  • Paulo Paes de Andrade, Professor, Universidade Federal de Pernambuco
  • Gabriel Ferrato, Mayor, Piracicaba (SP)
  • Marcelo de Franco, Vice Director, Innovation and Development, Butantan Institute
  • Luiz Reis, Director of Teaching and Research, Hospital Sirio-Libanes


Genetic Medicines Come of Age: The Challenges and Opportunities

The field of medical genetics continues to open new opportunities in diagnosis, management and counselling of patients with genetic disorders. While areas such as gene therapy, personalized medicine and predicative medicine continue to rapidly improve our understanding and ability to treat to genetic disorders, we still face many challenges in this space. This session will cover opportunities and challenges in personalized health and molecular diagnostics and the contributions that the world can expect from Latin America.

Moderator: Eduardo Emrich, President & Chief Executive Officer, Biominas Brasil


  • Bruno Soares, Chief Executive Officer, Coimbra Genomics
  • Emmanuel Dias-Neto, Head of Medical Genomics, A.C.Camargo Cancer Center
  • Xavier Soberón Mainero, General Director, Instituto Nacional de Medicina Genómica (INMEGEN)
  • Patricia Munerato, Executive Director of Genetic Science and Clinical Division, Thermo Fisher Scientific for Latin America


How the Biotech Revolution is Transforming Crop Protection

Panelists will focus on the benefits biotechnology brings to agriculture and the world through enabling sustainable food production. Revolutionary, environmentally friendly crop protection technologies will be discussed.

Moderator: Paula Carneiro, Director, Céleres


  • Sekhar Boddupalli, President, Intrexon Crop Protection
  • Adalecio Kovaleski, Researcher, Embrapa


Fireside Chat

Moderator: Justin Duarte Pine, Director, International Affairs, BIO


  • Rogerio Ribeiro, Senior Vice President, Emerging Markets and Asia Pacific, GlaxoSmithKline (GSK)


Trends in Emerging Therapeutic Company Deal-Making and R&D Productivity

The ability to access capital and form strategic alliances is vital for small therapeutic-focused companies to succeed in translating novel drug candidates into approved medical products for patients. BIO's David Thomas will be presenting trends seen in deal-making and R&D over the last decade. The state of venture funding, public investment (IPOs and follow-ons), licensing, and M&A will include a cross-sectional analysis by major disease areas. An investigation into R&D productivity will cover the largest study ever on clinical trial success rates. The analysis, conducted in collaboration with Biomedtracker, will cover ~10,000 clinical program transitions from 2006-2015. Individual therapeutic areas will be examined, as well as answers to long held questions: Do selection biomarkers yield higher success? Are rare disease programs experiencing higher success rates? Are biologics R&D programs more successful than small molecule programs?


  • David Thomas, Senior Director, Industry Research and Policy Analysis, BIO


The Future of Biotherapeutics in Latin America: From Biosimilars to Innovative Products

This panel will focus on the opportunities in Latin America to contribute towards the development of innovative biologics. The infrastructure for pre-clinical and clinical studies will be reviewed, as well as the role of universities and the private sector in helping to translate basic research to more advanced projects. Perspectives from patient advocacy groups and from the investment community will also be shared.

Moderator: Gustavo de Freitas Morais, Partner,  Danneman Siemsen


  • Ricardo Garcia, Director, CLAPBio
  • Marité Prieto, Regulatory Affairs Director, Amgen
  • Rodrigo Silvestre, Director of the Department of Health and Innovation Industrial Complex, Secretariat of Science, Technology and Strategic Inputs, Ministry of Health
  • Priscila Torres, President, BIORED Brasil